Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11969415 (methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Patent 11969415 was granted and assigned to Deciphera Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Deciphera Pharmaceuticals

Current Assignee

Deciphera Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119694150

Patent Inventor Names

Fred Jordan0

Scott Bone0

Michael D. Kaufman0

Corey Bloom0

Date of Patent

April 30, 2024

Patent Application Number

185181000

Date Filed

November 22, 2023

Patent Citations

‌

US Patent 7202257 Anti-inflammatory medicaments

‌

US Patent 7211575 Methods of treating cytokine mediated diseases

‌

US Patent 7279576 Anti-cancer medicaments

‌

US Patent 7342037 Anti-inflammatory medicaments

‌

US Patent 7531566 Anti-inflammatory medicaments

‌

US Patent 7666895 Anti-inflammatory medicaments

‌

US Patent 7737283 Anti-inflammatory medicaments

‌

US Patent 6916924 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11969415 (methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API